Company · CIK 0001516551 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Skye Bioscience, Inc. · SKYE
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 22, 2026 SForm 4 → | Sep 24, 4:31 pm EDT | Andrew J. SchwabDirector, 10% Owner | 148,079 | $1.62 | $239,555 | 0 | −100% | |
| Sep 22, 2026 SForm 4 → | Sep 24, 4:29 pm EDT | 5AM Partners VII, LLC +710% Owner | 148,079 | $1.62 | $239,555 | 0 | −100% | |
| Sep 16, 2026 SForm 4 → | Sep 18, 6:39 pm EDT | Andrew J. SchwabDirector, 10% Owner | 33,892 | $1.91 | $64,734 | 5,616 | −85.8% | |
| Sep 16, 2026 SForm 4 → | Sep 18, 6:37 pm EDT | 5AM Partners VII, LLC +710% Owner | 33,892 | $1.91 | $64,734 | 5,616 | −85.8% | |
| Aug 18, 2026 SForm 4 → | Aug 20, 5:59 pm EDT | Andrew J. SchwabDirector, 10% Owner | 375,840 | $0.3733 | $140,313 | 7,850,155 | −4.57% | |
| Aug 18, 2026 SForm 4 → | Aug 20, 5:57 pm EDT | 5AM Partners VII, LLC +710% Owner | 375,840 | $0.3733 | $140,313 | 7,850,155 | −4.57% | |
| Aug 7, 2026 AForm 4 → | Aug 7, 5:37 pm EDT | Punit DhillonChief Executive Officer, Director | 1,090,000 | — | — | 1,419,823 | — | |
| Dec 27, 2018 JForm 4 → | Dec 28, 6:59 pm EST | Emerald Health Sciences Inc.10% Owner | 37,667 | — | — | 73,153,917 | — | plan? |
| Jul 23, 2018 AForm 4 → | Jul 23, 5:18 pm EDT | Douglas A CesarioCFO and Secretary | 643,501 | — | — | 643,501 | — | plan? |
| Mar 29, 2018 CForm 4 → | Apr 3, 9:10 pm EDT | Emerald Health Sciences Inc.10% Owner | 32,335,000 | $0.10 | $3,233,500 | 73,116,250 | — | plan? |
| Feb 16, 2018 PForm 4 → | Feb 21, 4:32 pm EST | Emerald Health Sciences Inc.10% Owner | 15,000,000 | — | — | 39,000,000 | — | plan? |
| Jan 24, 2018 XForm 4 → | Mar 2, 7:46 pm EST | Emerald Health Sciences Inc.10% Owner | 1,781,250 | $0.001 | $1,781 | 40,781,250 | — | plan? late |
| Jan 18, 2018 AForm 4 → | Jan 22, 5:24 pm EST | Brian Stuart MurphyCEO, Chief Medical Officer, Director | 900,000 | — | — | 1,275,000 | — | plan? |
| Jan 18, 2018 AForm 4 → | Jan 22, 5:24 pm EST | Cosmas N LykosChairman, Director, 10% Owner | 900,000 | — | — | 4,599,400 | — | plan? |
| Jan 18, 2018 AForm 4 → | Jan 22, 5:23 pm EST | Elizabeth BereczChief Financial Officer | 700,000 | — | — | 1,050,000 | — | plan? |
| Mar 13, 2017 XForm 4 → | Mar 28, 10:52 am EDT | Reg Alexander Lapham10% Owner | 119,700 | $1.00 | $119,700 | 3,787,500 | — | plan? late |
| Oct 20, 2015 AForm 4 → | Oct 22, 9:35 pm EDT | Douglas S IngramVice Chairman, Director | 60,000 | — | — | 372,500 | — | plan? |
| Oct 20, 2015 AForm 4 → | Oct 22, 5:47 pm EDT | Gerald W. McLaughlinDirector | 30,000 | — | — | 61,250 | — | plan? |
| Oct 20, 2015 AForm 4 → | Oct 22, 5:45 pm EDT | Thomas GeorgeDirector | 60,000 | — | — | 60,000 | — | plan? |
| Oct 20, 2015 AForm 4 → | Oct 22, 5:40 pm EDT | Cosmas N LykosChairman, Director, 10% Owner | 325,000 | — | — | 3,699,400 | — | plan? |
| Oct 20, 2015 AForm 4 → | Oct 22, 5:39 pm EDT | Elizabeth BereczChief Financial Officer | 350,000 | — | — | 350,000 | — | plan? |
| Oct 20, 2015 AForm 4 → | Oct 22, 5:36 pm EDT | Brian Stuart MurphyCEO, Chief Medical Officer, Director | 375,000 | — | — | 375,000 | — | plan? |
| Aug 20, 2015 CForm 4 → | Aug 24, 8:21 pm EDT | Douglas S IngramVice Chairman, Director | 312,500 | — | — | 312,500 | — | plan? |
| Aug 20, 2015 CForm 4 → | Aug 24, 8:19 pm EDT | Gerald W. McLaughlinDirector | 31,250 | — | — | 31,250 | — | plan? |
| Apr 8, 2015 SForm 4 → | Apr 10, 5:23 pm EDT | Brian D Ladin10% Owner | 50,630 | $4.78 | $241,885 | 249,098 | −16.9% | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 1, 2019 JForm 4 → | Feb 1, 4:51 pm EST | Emerald Health Sciences Inc.10% Owner | 2,500,000 | — | — | 2,500,000 | — | |
| Nov 1, 2018 JForm 4 → | Nov 1, 6:45 pm EDT | Emerald Health Sciences Inc.10% Owner | 2,500,000 | — | — | 2,500,000 | — | |
| Oct 10, 2018 AForm 4 → | Oct 12, 1:05 pm EDT | Avtar S DhillonDirector | 1,000,000 | — | — | 1,000,000 | — | |
| Oct 10, 2018 AForm 4 → | Oct 12, 12:19 pm EDT | James L HeppellDirector | 200,000 | — | — | 200,000 | — | |
| Oct 10, 2018 AForm 4 → | Oct 12, 12:17 pm EDT | Punit DhillonDirector | 200,000 | — | — | 200,000 | — | |
| Jul 23, 2018 AForm 4 → | Jul 23, 5:18 pm EDT | Douglas A CesarioCFO and Secretary | 1,195,073 | — | — | 1,195,073 | — | |
| Mar 29, 2018 CForm 4 → | Apr 3, 9:10 pm EDT | Emerald Health Sciences Inc.10% Owner | 3,234 | — | — | 0 | — | |
| Feb 16, 2018 PForm 4 → | Feb 21, 4:32 pm EST | Emerald Health Sciences Inc.10% Owner | 20,400,000 | — | — | 20,400,000 | — | |
| Jan 24, 2018 XForm 4 → | Mar 2, 7:46 pm EST | Emerald Health Sciences Inc.10% Owner | 1,781,250 | — | — | 0 | — | late |
| Aug 20, 2015 CForm 4 → | Aug 24, 8:21 pm EDT | Douglas S IngramVice Chairman, Director | 100,000 | — | — | 0 | — | |
| Aug 20, 2015 CForm 4 → | Aug 24, 8:19 pm EDT | Gerald W. McLaughlinDirector | 10,000 | — | — | 0 | — | |
| Jun 1, 2015 AForm 4 → | Jun 3, 7:34 pm EDT | Douglas S IngramVice Chairman, Director | 40,000 | — | — | 40,000 | — | |
| May 29, 2015 PForm 4 → | Jun 2, 5:27 pm EDT | Gerald W. McLaughlinDirector | 12,000 | $2.50 | $25,000 | 2,000 | — | |
| Jan 9, 2015 AForm 4 → | Jan 12, 8:33 pm EST | Thomas GeorgeDirector | 40,000 | — | — | 40,000 | — |